Annual EBITDA
-$1.43 M
+$682.60 K+32.36%
December 1, 2023
Summary
- As of March 10, 2025, SXTP annual EBITDA is -$1.43 million, with the most recent change of +$682.60 thousand (+32.36%) on December 1, 2023.
- During the last 3 years, SXTP annual EBITDA has fallen by -$1.09 million (-318.08%).
- SXTP annual EBITDA is now -318.08% below its all-time high of -$341.20 thousand, reached on December 1, 2020.
Performance
SXTP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.14 M
+$2.02 M+48.45%
September 1, 2024
Summary
- As of March 10, 2025, SXTP quarterly EBITDA is -$2.14 million, with the most recent change of +$2.02 million (+48.45%) on September 1, 2024.
- Over the past year, SXTP quarterly EBITDA has stayed the same.
- SXTP quarterly EBITDA is now -150.58% below its all-time high of $4.24 million, reached on September 1, 2023.
Performance
SXTP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$7.87 M
-$6.38 M-429.61%
September 1, 2024
Summary
- As of March 10, 2025, SXTP TTM EBITDA is -$7.87 million, with the most recent change of -$6.38 million (-429.61%) on September 1, 2024.
- Over the past year, SXTP TTM EBITDA has stayed the same.
- SXTP TTM EBITDA is now -1831.35% below its all-time high of $454.50 thousand, reached on March 1, 2024.
Performance
SXTP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SXTP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.4% | 0.0% | 0.0% |
| 3 y3 years | -318.1% | 0.0% | 0.0% |
| 5 y5 years | -318.1% | 0.0% | 0.0% |
SXTP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.6% | +32.4% | -150.6% | +48.5% | -1831.3% | at low |
| 5 y | 5-year | -318.1% | +32.4% | -150.6% | +48.5% | -1831.3% | at low |
| alltime | all time | -318.1% | +32.4% | -150.6% | +48.5% | -1831.3% | at low |
60 Degrees Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.14 M(-48.4%) | -$7.87 M(+429.6%) |
| Jun 2024 | - | -$4.16 M(-1021.0%) | -$1.49 M(-426.9%) |
| Mar 2024 | - | $451.60 K(-122.4%) | $454.50 K(-131.9%) |
| Dec 2023 | -$1.43 M | -$2.02 M(-147.6%) | -$1.43 M(-3084.5%) |
| Sep 2023 | - | $4.24 M(-291.0%) | $47.80 K(-101.1%) |
| Jun 2023 | - | -$2.22 M(+55.2%) | -$4.41 M(+29.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$1.43 M(+163.3%) | -$3.41 M(+61.8%) |
| Dec 2022 | -$2.11 M(+107.8%) | -$542.90 K(+152.5%) | -$2.11 M(+5.9%) |
| Sep 2022 | - | -$215.00 K(-82.5%) | -$1.99 M(+12.1%) |
| Jun 2022 | - | -$1.23 M(+870.8%) | -$1.78 M(+222.1%) |
| Mar 2022 | - | -$126.20 K(-70.3%) | -$551.50 K(+29.7%) |
| Dec 2021 | -$1.01 M(+197.4%) | -$425.30 K | -$425.30 K |
| Dec 2020 | -$341.20 K | - | - |
FAQ
- What is 60 Degrees Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals annual EBITDA year-on-year change?
- What is 60 Degrees Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals quarterly EBITDA year-on-year change?
- What is 60 Degrees Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for 60 Degrees Pharmaceuticals?
- What is 60 Degrees Pharmaceuticals TTM EBITDA year-on-year change?
What is 60 Degrees Pharmaceuticals annual EBITDA?
The current annual EBITDA of SXTP is -$1.43 M
What is the all time high annual EBITDA for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high annual EBITDA is -$341.20 K
What is 60 Degrees Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, SXTP annual EBITDA has changed by +$682.60 K (+32.36%)
What is 60 Degrees Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of SXTP is -$2.14 M
What is the all time high quarterly EBITDA for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high quarterly EBITDA is $4.24 M
What is 60 Degrees Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, SXTP quarterly EBITDA has changed by $0.00 (0.00%)
What is 60 Degrees Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of SXTP is -$7.87 M
What is the all time high TTM EBITDA for 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals all-time high TTM EBITDA is $454.50 K
What is 60 Degrees Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, SXTP TTM EBITDA has changed by $0.00 (0.00%)